IM-9(人外周血B淋巴瘤細(xì)胞)
CBP60276
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. General information | |
Synonyms: | IM-9 |
Background: | Although derived from the blood of a patient with multiple myeloma, this line has been shown to be an EBV-transformed B lymphoblastoid cell line. |
Species: | Homo sapiens, human |
Tissue: | peripheral blood |
Disease: | multiple myeloma |
Gender: | female, Caucasian |
Morphology: | lymphoblast |
Growth Mode: | suspension |
DNA Profile: | Amelogenin: X CSF1PO: 10,11 D13S317: 9,11 D16S539: 9,13 D5S818: 13 D7S820: 11,12 THO1: 6,9.3 TPOX: 11 vWA: 14,17 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS IM-9完全培養(yǎng)基,# CBP60276M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | CD11a +; CD19 +; CD20 +; CD38 -; CD49e + |
Receptor Expression: | growth hormone receptor insulin receptor calcitonin receptor |
Genes Expressed: | immunoglobulin |
Cellular Products: | immunoglobulin |
Comments: | The cells are EBNA positive. ATCC confirmed this cell line is positive for the presence of Epstein-Barr (EBV) viral DNA sequences via PCR. For more information, please contact Cobioer (4008-750-250). |